LEPTIN AND ADIPONECTIN CONTENT IN BLOOD SERUM AND RECEPTOR EXPRESSION IN OSTEOPENIA AND OSTEOPOROSIS IN PATIENTS SUFFERING FROM CHRONIC OBSTRUCTIVE PULMONARY DISEASE

The purpose is to identify the leptin and adiponectin content in blood regarding their receptor expression in the soft tissue of the hip in case of chronic obstructive pulmonary disease with the signs of osteporosis.80 COPD patients and 76 healthy persons were examined. Receptor expression to leptin and adiponectin in the vessels was tested by immune-fluorescent technique in 30 patients.Control leptin and adiponectin expression was presented in skin, subcutaneous fat and cross-striped muscles. In case of COPD leptin and adiponectin expression was identified in skin and subcutaneous fat. In control cases and COPD leptin expression was identified in endothelium and myocytes achieving confident reduction at stages II and III. Adiponectin expression in control cases and in stage I was detection only in adventitia. In stages II and III stages adiponectin is expressed in myocytes and endothelium. Receptor expression to leptin and adiponectin repeats their content in blood. The correlations between leptin and adiponectin and their expression with body mass index and mineral bone density have been found out.The detected changes confirm the contribution of adiponectin to re-modeling of muscle and bone tissue in case of COPD.